GLP1R agonists like lixisenatide, exenatide, or semaglutide limit the progression of motor dysfunction in Parkinson’s disease.
Mounjaro
Posted inClinical Trials, In the Pipeline, Metabolism
Most Effective Weight Loss Drugs: Present and Future
Modern pharmacological ways to combat obesity.
Posted inClinical Trials, Metabolism
Tirzepatide: Strong Weight-Loss Drug
Losing 24 kilograms in a year and a half.
Posted inMetabolism, New Drugs, Regulatory
Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus
Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.